In patients with RRMS, high level of CHI3L1 in CSF is an independent predictor of the deterioration of neurological dysfunction and the progression of the disease to SPMS. Therefore, CHI3L1 in CSF may predict the progression of RRMS (37–40). The gene discussed is CHI3L1; the disease is secondary progressive multiple sclerosis.